Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,961 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biology and management of mantle cell lymphoma.
Leonard JP, Schattner EJ, Coleman M. Leonard JP, et al. Among authors: coleman m. Curr Opin Oncol. 2001 Sep;13(5):342-7. doi: 10.1097/00001622-200109000-00005. Curr Opin Oncol. 2001. PMID: 11555710 Review.
CD22-directed monoclonal antibody therapy for lymphoma.
Siegel AB, Goldenberg DM, Cesano A, Coleman M, Leonard JP. Siegel AB, et al. Among authors: coleman m. Semin Oncol. 2003 Aug;30(4):457-64. doi: 10.1016/s0093-7754(03)00240-9. Semin Oncol. 2003. PMID: 12939714 Review.
Epratuzumab in non-Hodgkin's lymphomas.
Furman RR, Coleman M, Leonard JP. Furman RR, et al. Among authors: coleman m. Curr Treat Options Oncol. 2004 Aug;5(4):283-8. doi: 10.1007/s11864-004-0019-1. Curr Treat Options Oncol. 2004. PMID: 15233905 Review.
Outcome of deferred initial therapy in mantle-cell lymphoma.
Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, Elstrom R, Niesvizky R, Ely S, Diliberto M, Melnick A, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP. Martin P, et al. Among authors: coleman m. J Clin Oncol. 2009 Mar 10;27(8):1209-13. doi: 10.1200/JCO.2008.19.6121. Epub 2009 Feb 2. J Clin Oncol. 2009. PMID: 19188674
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
Ruan J, Martin P, Coleman M, Furman RR, Cheung K, Faye A, Elstrom R, Lachs M, Hajjar KA, Leonard JP. Ruan J, et al. Among authors: coleman m. Cancer. 2010 Jun 1;116(11):2655-64. doi: 10.1002/cncr.25055. Cancer. 2010. PMID: 20235190 Free PMC article. Clinical Trial.
2,961 results